| Source of funding | No conclusion on reported outcome | Positive | Negative | Pearson’s chi Square | Fisher’s exact p value |
---|---|---|---|---|---|---|
n (%)$$ | n (%)$$ | n (%)$$ | ||||
NEC N = 12 | Industry | 3 (25) |  | 1 (8.3) | 0.511 | 0.782 |
 | None/Not clear | 2 (16.7) | 1 (8.3) | 1 (8.3) |  |  |
 | Non industry | 2 (16.7) | 2 (16.7) | 0 |  |  |
 |  | 7 (58.3) | 3 (25) | 2 (16.7) |  |  |
Sepsis N = 10 | Industry | 2 (20) |  |  | 0.274 | 0.500 |
 | None/Not clear | 2 (20) |  | 1 (10) |  |  |
 | Non industry | 5 (50) |  |  |  |  |
Antibiotic use N = 16 | Industry | 4 (25) | 3 (18.8) |  | 0.093 | 0.141 |
 | None/Not clear | 4 (25) |  |  |  |  |
 | Non industry | 5 (31.3) |  |  |  |  |